How did clinical chemists respond to Elizabeth Holmes explanations? (Theranos)

A rare Q&A between Elizabeth Holmes of Theranos and actual scientists from 2016. Sources American Association of Clinical Chemistry Presentation “On August 1, 2016 at the 68th AACC Annual Scientific Meeting, Theranos CEO Elizabeth Holmes gave a presentation on her company’s technology. In this special session, Holmes discussed a compact instrument called “miniLab,” the inside of a cartridge-based testing system, video and description of micro-collection devices, and a concept called a virtual analyzer. Following the presentation by Ms. Holmes, a moderator-led Q&A session featured questions submitted in real-time by members of the audience. The moderator panel included 2016 AACC President Dr. Patricia Jones, and Drs. Y.M. Dennis Lo and Stephen Master.“